Published in AIDS on July 01, 1991
Antiviral therapy for human immunodeficiency virus infections. Clin Microbiol Rev (1995) 1.49
Safety, activity, and pharmacokinetics of GLQ223 in patients with AIDS and AIDS-related complex. Antimicrob Agents Chemother (1994) 0.85
The membrane insertion of trichosanthin is membrane-surface-pH dependent. Biochem J (2000) 0.81
Trichosanthin, an initiator of the alternative complement activation pathway. Clin Exp Immunol (1993) 0.75
European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci (1996) 6.12
Use of an intramedullary hip-screw compared with a compression hip-screw with a plate for intertrochanteric femoral fractures. A prospective, randomized study of one hundred patients. J Bone Joint Surg Am (1998) 2.83
Geographical prevalence of two types of Epstein-Barr virus. Virology (1986) 2.05
In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype. Blood (1998) 1.98
Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM. Immunity (1998) 1.96
Nasopharyngeal carcinoma. X. Presence of epstein-barr genomes in separated epithelial cells of tumours in patients from Singapore, Tunisia and Kenya. Int J Cancer (1975) 1.95
Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. J Clin Invest (1996) 1.79
Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells. AIDS Res Hum Retroviruses (1993) 1.67
A 500-kiloton airburst over Chelyabinsk and an enhanced hazard from small impactors. Nature (2013) 1.61
European stroke prevention study: effectiveness of antiplatelet therapy in diabetic patients in secondary prevention of stroke. Stroke (1992) 1.59
Identification of three major phosphorylation sites within HIV-1 capsid. Role of phosphorylation during the early steps of infection. J Biol Chem (1999) 1.45
Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion. J Exp Med (1991) 1.44
Postoperative radiation therapy in lung caner: a controlled trial after resection of curative design. Int J Radiat Oncol Biol Phys (1980) 1.38
Characterization of human monoclonal antibodies specific to the hepatitis C virus glycoprotein E2 with in vitro binding neutralization properties. Virology (1998) 1.37
Separation of human lymphocytes forming spontaneous rosettes with sheep erythrocytes. Biomedicine (1973) 1.30
Asymptomatic autoimmune thyroiditis and coronary heart-disease. Cross-sectional and prospective studies. Lancet (1977) 1.28
Extracellular nucleotides induce arterial smooth muscle cell migration via osteopontin. Circ Res (2001) 1.26
P2Y(1), P2Y(2), P2Y(4), and P2Y(6) receptors are coupled to Rho and Rho kinase activation in vascular myocytes. Am J Physiol Heart Circ Physiol (2000) 1.24
Lymphoblastoid transformation and kinetics of appearance of viral nuclear antigen (EBNA) in cord-blood lymphocytes infected by Epstein-Barr Virus (EBV). Int J Cancer (1975) 1.23
Herpes simplex virus glycoprotein D: human monoclonal antibody produced by bone marrow cell line. Science (1983) 1.19
Epstein-Barr virus-specific transcription in normal and malignant nasopharyngeal biopsies and in lymphocytes from healthy donors and infectious mononucleosis patients. J Gen Virol (1987) 1.16
Dynamic analysis of hepatitis C virus replication and quasispecies selection in long-term cultures of adult human hepatocytes infected in vitro. J Gen Virol (1999) 1.13
Profound immunosuppression across the spectrum of opportunistic disease among hospitalized HIV-infected adults in Abidjan, Côte d'Ivoire. AIDS (1997) 1.11
Structure of the O-specific polysaccharide chain of Klebsiella pneumoniae O1K2 (NCTC 5055) lipopolysaccharide. A complementary elucidation. Carbohydr Res (1992) 1.10
Osteopontin overexpression is associated with arterial smooth muscle cell proliferation in vitro. Arterioscler Thromb (1993) 1.10
Role of adenosine kinase in Saccharomyces cerevisiae: identification of the ADO1 gene and study of the mutant phenotypes. Yeast (2001) 1.09
Association of ERK2 mitogen-activated protein kinase with human immunodeficiency virus particles. J Virol (1997) 1.07
Overexpression of P2Y2 purinoceptor in intimal lesions of the rat aorta. Arterioscler Thromb Vasc Biol (1997) 1.07
Evaluation of computer-ECG programs. The strange case of the Golden standard. Comput Biomed Res (1979) 1.07
Nasopharyngeal carcinoma (NPC). I. Types of cultures derived from tumour biopsies and non-tumorous tissues of Chinese patients with special reference to lymphoblastoid transformation. Int J Cancer (1970) 1.06
Y-chromosome-specific haplotype diversity in Ashkenazic and Sephardic Jews. Hum Biol (1993) 1.05
Structure of the O-specific polysaccharide chain from Klebsiella pneumoniae O1K2 (NCTC 5055) lipopolysaccharide. Carbohydr Res (1991) 1.03
Lymphocytes in infectious mononucleosis. Properties of atypical cells and origin on the lymphoblastoid lines. Biomedicine (1973) 1.02
Synthesis and antiviral activity of (E)-5-(2-bromovinyl)uracil and (E)-5-(2-bromovinyl)uridine. J Med Chem (1986) 1.01
Catabolism of thymidine in human blood platelets: purification and properties of thymidine phosphorylase. Biochim Biophys Acta (1981) 1.00
Extracellular adenosine induces apoptosis of human arterial smooth muscle cells via A(2b)-purinoceptor. Circ Res (2000) 0.99
HCV core immunodominant region analysis using mouse monoclonal antibodies and human sera: characterization of major epitopes useful for antigen detection. J Med Virol (1998) 0.99
T lymphocyte cloning from rejected human kidney allografts. Growth frequency and functional/phenotypic analysis. J Clin Invest (1986) 0.98
Phosphorolysis of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and other 5-substituted-2'-deoxyuridines by purified human thymidine phosphorylase and intact blood platelets. Biochem Pharmacol (1983) 0.97
Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C. J Med Virol (2007) 0.97
Exogenous ATP induces a limited cell cycle progression of arterial smooth muscle cells. Am J Physiol (1993) 0.96
Regeneration of the antiviral drug (E)-5-(2-bromovinyl)-2'-deoxyuridine in vivo. Nucleic Acids Res (1984) 0.96
Persistence of human adenovirus 5 in human cord blood lymphoblastoid cell lines transformed by Epstein-Barr virus. Infect Immun (1980) 0.95
Evidence for diversity of Plasmodium falciparum sporozoite surface antigens derived from analysis of antibodies elicited in humans. Infect Immun (1990) 0.95
Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients. J Infect Dis (2000) 0.94
Monoclonal antibodies to HIV in a non-infected, immunised volunteer. Lancet (1988) 0.94
Effect of (E)-5-(2-bromovinyl)uracil on the catabolism and antitumor activity of 5-fluorouracil in rats and leukemic mice. Cancer Res (1986) 0.94
Time course of osteopontin, osteocalcin, and osteonectin accumulation and calcification after acute vessel wall injury. J Histochem Cytochem (2001) 0.94
Bone-targeted Src SH2 inhibitors block Src cellular activity and osteoclast-mediated resorption. Bone (2001) 0.93
Murine monoclonal antibodies to Klebsiella pneumoniae protect against lethal endotoxemia and experimental infection with capsulated K. pneumoniae. Infect Immun (1990) 0.93
YLR209c encodes Saccharomyces cerevisiae purine nucleoside phosphorylase. J Bacteriol (2001) 0.93
The human blood platelet: a cellular model to study the degradation of thymidine and its inhibition. Biochem Pharmacol (1982) 0.92
Tiapride versus placebo: a double-blind comparative study in the management of Huntington's chorea. Curr Med Res Opin (1984) 0.92
Clinical evaluation of the branched DNA assay for hepatitis B virus DNA detection in patients with chronic hepatitis B lacking hepatitis B e antigen and treated with interferon-alpha. J Viral Hepat (1998) 0.91
Nucleotide receptor P2u partially mediates ATP-induced cell cycle progression of aortic smooth muscle cells. J Cell Physiol (1996) 0.91
Investigations into the cross-reactivity of rabbit antibodies raised against nonhomologous pairs of synthetic peptides derived from HIV-1 gp120 proteins. J Pept Res (1998) 0.91
Presence of EBV-DNA sequences in nasopharyngeal cells of individuals without IgA-VCA antibodies. Int J Cancer (1983) 0.91
Protective effects of murine monoclonal antibodies in experimental septicemia: E. coli antibodies protect against different serotypes of E. coli. J Infect Dis (1989) 0.91
Effects of food ingestion on the cell proliferation kinetics in the canine fundic mucosa. Gastroenterology (1971) 0.90
Herpes simplex-RAJI(A44), a new cell line for serologic testing by immunofluorescence. J Immunol (1976) 0.88
In vitro transforming activity of EBV. I-Establishment and properties of two EBV strains (M81 and M72) produced by immortalized Callithrix jacchus lymphocytes. Biomedicine (1976) 0.87
Origins of Falasha Jews studied by haplotypes of the Y chromosome. Hum Biol (1999) 0.86
Cell proliferation in the mucosa of Heidenhain pouches after feeding in dogs. Am J Dig Dis (1972) 0.86
AP-1 is involved in UTP-induced osteopontin expression in arterial smooth muscle cells. Circ Res (2003) 0.86
Matrix metalloproteinase 9 (gelatinase B) in cerebrospinal fluid of HTLV-1 infected patients with tropical spastic paraparesis. Neurology (1998) 0.85
Escherichia coli pyometra induces transient glomerular and tubular dysfunction in dogs. J Vet Intern Med (2010) 0.85
Cell surface phenotypic changes induced in H9 T cells chronically infected with HTLV type I or HIV type 1 or coinfected with the two viruses. AIDS Res Hum Retroviruses (1995) 0.85
Complement receptor type 2 mediates infection of the human CD4-negative Raji B-cell line with opsonized HIV. Scand J Immunol (1992) 0.85
In vitro infection of epidermal Langerhans cells with human immunodeficiency virus type 1 (HTLV-IIIB isolate). Res Virol (1993) 0.84
Establishment of human cell lines producing anti-D monoclonal antibodies: identification of Rhesus D antigen. Immunol Lett (1986) 0.84
Infectious mononucleosis-like response in common marmosets infected with Epstein-Barr virus. J Infect Dis (1984) 0.84
Effect of thyroxine supplementation on glomerular filtration rate in hypothyroid dogs. J Vet Intern Med (2009) 0.84
Evaluation of kidney injury in dogs with pyometra based on proteinuria, renal histomorphology, and urinary biomarkers. J Vet Intern Med (2011) 0.84
Molecular characterization of human monoclonal antibodies specific for several HIV proteins: analysis of the VH3 family expression. Immunol Lett (1996) 0.83
Maternal humoral factors associated with perinatal human immunodeficiency virus type-1 transmission in a cohort from Kigali, Rwanda, 1988-1994. J Infect (1999) 0.83
In vitro analysis of complement-dependent HIV-1 cell infection using a model system. J Immunol (1999) 0.83
Long terminal repeat sequence analysis of HTLV type I molecular variants identified in four north African patients. AIDS Res Hum Retroviruses (1994) 0.83
Inhibition of production of tumor necrosis factor by monoclonal antibodies to lipopolysaccharides. J Infect Dis (1992) 0.83
Recent evidence of underestimated circulation of hepatitis C virus intergenotypic recombinant strain RF2k/1b in the Rhône-Alpes region, France, January to August 2014: implications for antiviral treatment. Euro Surveill (2014) 0.83
ATP raises [Ca2+]i via different P2-receptor subtypes in freshly isolated and cultured aortic myocytes. Am J Physiol (1995) 0.82
Induction of cell cycle-dependent genes during cell cycle progression of arterial smooth muscle cells in culture. J Cell Physiol (1991) 0.82
The N-terminus of HIV-1 Tat protein is essential for Tat-TAR RNA interaction. Cell Mol Life Sci (2005) 0.82
Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I) Int J Cancer (1998) 0.82
Cell cycle dependent gene expression in quiescent stimulated and asynchronously cycling arterial smooth muscle cells in culture. J Cell Physiol (1992) 0.82
Purification of human alpha 1 antiprotease-pancreatic elastase complex. Interaction with homologous elastin. Connect Tissue Res (1984) 0.82
Assessment of renal dysfunction using urinary markers in canine babesiosis caused by Babesia rossi. Vet Parasitol (2012) 0.82
Transient adult T-cell leukemia/lymphoma picture during varicella infection in an HTLV-1 carrier. Leukemia (1994) 0.82
Important B-cell epitopes for neutralization of human immunodeficiency virus type 1 Tat in serum samples of humans and different animal species immunized with Tat protein or peptides. J Gen Virol (2004) 0.81
Detection of HTLV-1 DNA by polymerase chain reaction in alveolar lymphocytes of patients with tropical spastic paraparesis. J Infect Dis (1989) 0.81